The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 11, 2022

Filed:

Jan. 28, 2020
Applicant:

Junctucell Biomed Manufacturing Gmbh, Hohenbrunn, DE;

Inventors:

Christine Günther, Munich, DE;

Stefanos Theoharis, Munich, DE;

Felix Hermann, Munich, DE;

Ralf Huss, Waakirchen, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/28 (2015.01); C07K 14/52 (2006.01); C12N 5/0775 (2010.01); A61K 35/17 (2015.01); C07K 14/54 (2006.01); C07K 14/555 (2006.01); C07K 14/705 (2006.01); C07K 16/30 (2006.01); A61K 35/12 (2015.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); A61K 35/17 (2013.01); C07K 14/52 (2013.01); C07K 14/54 (2013.01); C07K 14/555 (2013.01); C07K 14/70521 (2013.01); C07K 16/30 (2013.01); C12N 5/0663 (2013.01); A61K 38/00 (2013.01); A61K 2035/124 (2013.01); C12N 2510/02 (2013.01);
Abstract

A method of treating a tumor in a subject including administering a genetically modified mesenchymal stem cell (MSC), wherein the MSC includes one or more exogenous nucleic acid molecule(s), wherein the one or more exogenous nucleic acid molecule(s) includes one or more regions encoding two or more immune response-stimulating cytokines operably linked to one or more promoters or promoter/enhancer combinations, wherein the two or more immune response-stimulating cytokines include at least IL-7, and at least one of IL-12 or IL-21.


Find Patent Forward Citations

Loading…